Donepezil

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on October 27, 2022.

Return to the list of Patented Medicine Litigation page.





Donepezil

ARICEPT, ARICEPT RDT – Pfizer Canada Inc. (NOC Search)

Patents:

  • 1338808: EISAI, APOTEX, GENPHARM, EISAI, MYLAN, RATIOPHARM, EISAI, EISAI, MYLAN, RANBAXY, EISAI, EISAI, MINT, ACTAVIS, EISAI, PHARMASCIENCE, EISAI
  • 2252806: EISAI, MINT, EISAI, ACCORD HEALTHCARE, RATIOPHARM, EISAI, RANBAXY, EISAI, EISAI, APOTEX, GENPHARM, EISAI, MYLAN, ACTAVIS, EISAI, PHARMASCIENCE, EISAI, EISAI, AURO, EISAI, EISAI, SANDOZ

ACTAVIS, EISAI

AURO, EISAI

EISAI

EISAI, ACCORD HEALTHCARE

EISAI, APOTEX

EISAI, MINT

EISAI, MYLAN

EISAI, SANDOZ

GENPHARM, EISAI, MYLAN

PHARMASCIENCE, EISAI

RANBAXY, EISAI

RATIOPHARM, EISAI


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property